In an early animal test, a new nasal-spray vaccine has shown promise against a variety of germs and a common allergen, ...

Discovery caps 5-year journey to get to the bottom of one of the most puzzling chapters of the COVID-19 pandemic ...

A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled “Exploring the potential link between ...

After years of work, scientists have solved the mystery of an unusual side effect that impacted some recipients of the Oxford ...

Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper.

Rare but deadly blood clots tied to J&J and AstraZeneca's vaccines were caused by an autoimmune reaction that some people are predisposed to, researchers found.

Scientists found a vaccine link to rare clotting disorder vaccine-induced immune thrombocytopenia and thrombosis (VITT) ...

A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled ...

Researchers identify genetic mutation in small group of people who developed the serious disorder after receiving the AstraZeneca or Johnson & Johnson vaccine.

CHICAGO--(BUSINESS WIRE)--Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to ...

Researchers at Johns Hopkins Bloomberg School of Public Health have discovered a genetic mutation in the FluMist intranasal flu vaccine that has the potential to be altered to enhance the vaccine's ...